CFTR and cystic fibrosis: Along these lines, in our previous real world study evaluating the effects of lumacaftor-ivacaftor in F508del homozygous patients with CF, we found that ICM detected improvement in CFTR function in 95% of patients compared to 65% of patients showing functional improvement in response to therapy by NPD [45].